3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Vascular Diseases
1
Respiratory Tract Diseases
1
Pulmonary Embolism
1
Neoplasms
1
Lung Diseases
1
Embolism and Thrombosis
1
Embolism
1
Disease
1
Cardiovascular Diseases
1
Interventions
Exercise
83
Standard of Care
45
Blood Specimen Collection
43
Methods
32
Therapeutics
28
Surveys and Questionnaires
27
Educational Status
25
Control Groups
20
Cognitive Behavioral Therapy
20
Interviews as Topic
18
Music Therapy
15
Biopsy
15
Acupuncture Therapy
15
Palliative Care
14
Resistance Training
13
Magnetic Resonance Spectroscopy
13
Early Intervention, Educational
13
Radiotherapy
10
Radiosurgery
10
Nutrition Assessment
9
Behavior Therapy
9
Yoga
8
Psychiatric Rehabilitation
8
Practice Guidelines as Topic
8
Patient Navigation
8
Counseling
8
Ultraviolet Therapy
7
Physical Therapy Modalities
7
Nutritional Status
7
Mindfulness
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Neoplasms
×
4-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid
×
Clear all
NCT04657120
2025-12-23
HYDRA
Leiden University Medical Center
Phase NA
Completed
698 enrolled